Mycrodose Therapeutics

Mycrodose Therapeutics Inc. is a U.S.-based pharmaceutical company headquartered in San Diego, California, specializing in the development of advanced drug delivery systems that utilize DEA Schedule I, II, III drugs and other compounds to treat cancer-related conditions, mental health disorders, and cognitive degenerative diseases. Its IP-protected Sustained Microdosing Technolog™ represents a smarter, safer method for delivering highly effective drug compounds to patients of all ages. The company's focus on drug delivery technology enables the potential simultaneous development of dozens of unique products within its clinical pipeline.